芪参胶囊治疗冠心病心绞痛的临床疗效

Clinical effect by Qishen capsules in the treatment of coronary heart disease angina pectoris

目的观察芪参胶囊治疗冠心病心绞痛的临床疗效。方法 78例冠心病心绞痛患者根据抽签法分为对照组(40例)与实验组(38例),两组均给予肠溶阿司匹林+单硝酸异山梨酯缓释胶囊+美托洛尔治疗,实验组联用芪参胶囊,比较两组疗效。结果实验组治疗总有效率为97.4%,明显高于对照组的75.0%(P<0.05);治疗后实验组每周平均发作次数较对照组更少,每次持续时间更短(P<0.05)。结论芪参胶囊治疗冠心病心绞痛效果满意,可减少心绞痛发作次数,缩短病情持续时间,值得推广和应用。

Objective To observe clinical effect by Qishen capsules in the treatment of coronary heart disease angina pectoris. Methods A total of 78 patients with coronary heart disease angina pectoris were randomly divided into control group (40 cases) and experimental group (38 cases). Both groups received enteric-coated aspirin + isosorbide mononitrate sustained release capsules + metoprolol for treatment, while the experimental group received additional Qishen capsules for combined treatment. Curative effects were compared between the two groups. Results The experimental group had obviously higher total effective rate as 97.4%than 75.0% in the control group (P<0.05). After treatment, the experimental group had much lower mean weekly onset frequency and shorter duration than the control group (P<0.05). Conclusion Qishen capsules provides satisfactory effect in treating coronary heart disease angina pectoris. It can reduce angina pectoris onset frequency and shorten duration, and it is worth promoting and applying.